基本信息
views: 128
Career Trajectory
Bio
Dr. Seow’s primary clinical interest is in special populations in IBD, namely, pediatric to adult transition, sexual health and the management of pregnant women with IBD. Her research interests are in materno-fetal outcomes in IBD, pharmacokinetics of biologic therapies and preventive care. She is Associate Editor of Alimentary Pharmacology and Therapeutics, and on the Editorial Board of the Journal of the Canadian Association of Gastroenterology. Dr. Seow is the chair of the national Future Leaders in IBD (FLIBD) group.
Research Interests
Papers共 302 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
N S Ahmed, S Krawchuk, K Buhler,I Stukalin, J Besney, A Shaheen,C Seow,K Novak,R Ingram, C Lu, G,R Panaccione, C Ma
Journal of the Canadian Association of Gastroenterologyno. Supplement_1 (2024): 174-176
Gastroenterologyno. 5 (2024): S-527
Gastroenterologyno. 5 (2024): S-526
JOURNAL OF CROHNS & COLITIS (2024): I778-I778
Cited0Views0Bibtex
0
0
Gastroenterologyno. 5 (2024): S-527-S-528
The American journal of gastroenterology (2024)
R. Rosentreter,R. Ingram, C. Ma, M. Chan, T. Shukla,S. Devlin,G. Kaplan,C. Seow,R. Panaccione,K. Novak, C. Lu
JOURNAL OF CROHNS & COLITIS (2024): I1385-I1385
Cited0Views0Bibtex
0
0
Alimentary pharmacology & therapeuticsno. 9 (2024): 1234-1243
V. Gulhati,R. Rosentreter, M. Motamedi, A. Macci,R. Ingram,G. Kaplan, C. Ma,C. Seow,K. Novak,R. Panaccione, C. Lu
JOURNAL OF CROHNS & COLITIS (2024): I948-I948
Load More
Author Statistics
#Papers: 302
#Citation: 4958
H-Index: 34
G-Index: 68
Sociability: 7
Diversity: 3
Activity: 61
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn